Health Net Health Plan of Oregon Now Serving Washington Small Businesses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Leerink Partners Raised Price Target on Health Net (HNT) Following Investor Roadshow
June 5, 2015 9:32 AM EDTLeerink Partners maintains a Market Perform rating on Health Net (NYSE: HNT), and raised the price target to $65.00 (from $62.00), following investor roadshow. Analyst Ana Gupte believes that management is executing solidly against an ambitious agenda.
Gupte commented, "On May 27, we hosted an investor roadshow and a meaningful discussion with the entire C-suite of HNT led by Jay Gellert, CEO, at the Woodland Hills, CA, HQ. Clearly, HNT continues to execute solidly against an ambitious agenda set in motion by CEO and Chairman Jay Gellert... More



